In this episode, we explore the evolving landscape of targeted therapies in gynecologic oncology with three leading experts: Dr. Thomas J. Herzog (GOG Foundation), Professor Isabelle Ray-Coquard (ESMO), and Professor Jayanta Chatterjee (UK). From immunotherapy combinations to innovations in clinical trial design, our guests share insights into where the field is headed — and what it means for patients and practitioners alike. A must-listen for anyone passionate about the future of cancer care.